Key result
Reducing the induction volume of Complete Freund's Adjuvant to 20 µl for ankle injections and 50 µl for knee injections reduced local spread of inflammation without attenuating model validity.
Why the study?
This study aimed to compare the outcome of different injection volumes and joint locations of complete Freund's Adjuvant to refine the rodent monoarthritis model and improve its validity.
Reducing CFA induction volumes to 20 µl for ankle and 50 µl for knee injections refines the rat monoarthritis model by minimizing unintended spread of inflammation while maintaining model validity.
Answers are grounded in this paper and cite their sources.
Refines rodent CFA monoarthritis model parameters; leaves open translation to human arthritis therapies.
Arthritis is a highly prevalent and disabling condition characterized by pathological joint-damage, clinical symptoms of pain and loss of normal joint function. Monoarthritis can be modelled in rodents via intraarticular injection of complete Freund’s Adjuvant (CFA), inducing both joint inflammation and pain-like behaviours. This study aimed to compare the outcome of different injection-volumes and joint-locations, to refine the model’s use and to improve its validity. Male and female rats were injected with CFA into the ankle (10, 20 or 50 µl) or knee (10, 50 or 100 µl), and assessed on dynamic weight bearing, locomotor activity, depressive- and anxiety-like behaviours, histology, and a variety of welfare and model-specific parameters. Induction of monoarthritis resulted in relatively similar behavioural profiles regardless of the injected joint. The animals were highly affected in the acute phase, while less in the chronic phase. Greater volumes of CFA were associated with more profound behavioural changes and joint swelling. The largest volumes induced a pronounced local spread of inflammation to adjacent joints, which was reduced with intermediate volumes without attenuating the model validity. Reducing induction volumes to 20 and 50 µl CFA for ankle and knee injections, respectively, appears to be valuable refinement of these models.
No takes yet. Share an insight, caveat, or question.
Berke et al. (2025) studied Monoarthritis (animal model) (n=84). Complete Freund's Adjuvant (CFA) vs. Control was evaluated on Joint swelling, behavioral changes, and spread of inflammation. Reducing the induction volume of Complete Freund's Adjuvant to 20 µl for ankle injections and 50 µl for knee injections reduced local spread of inflammation without attenuating model validity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: